Through ectopic expression and knockdown studies, we found that BAF53A-induced ERK1/2 phosphorylation and CRC progression could be partially reversed by DUSP5, indicating the important role of DUSP5 in mediating BAF53A-induced CRC progression. This evidence concerns the gene ACTL6A and colorectal carcinoma.